Latest filing published 05 Jun 2026 for Hikma Pharmaceuticals PLC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +12.0%Entry £14.63 · Close 08 Oct 2026 £16.39
- +10.6%Entry £14.60 · Close at T+90 £16.15
- -30.1%Entry £21.04 · Close at T+365 £14.71
- -35.3%Entry £19.49 · Close at T+365 £12.61
- +9.9%Entry £18.47 · Close at T+365 £20.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Khalid Nabilsi: trading record in brief
Khalid Nabilsi appears in our data through filings on Hikma Pharmaceuticals PLC shares, published by RNS (LSE). Over a trading history stretching from 8 November 2013 to 1 June 2026, the count stands at 11 filings.
The open-market side counts 5 purchases alongside 3 sales for €1.9M. The totals exclude 5 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants. 2026 to date brings 2 purchases and no sales.
Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 5 June 2026, the filings show an open-market purchase in Hikma Pharmaceuticals PLC. The median gap between a trade and its publication by RNS (LSE) is 1 day. The regulation allows three business days to notify a trade (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Khalid Nabilsi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-2Canonical exit: 30 Aug 2026 (T+90)
- 73,859 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-2Canonical exit: 30 Aug 2026 (T+90)
- 100,792 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-2
- 28,833 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5680033-3Canonical exit: 28 Aug 2025 (T+90)
- 73,620 sharesOutside a trading venueISIN GB00B0LCW083RNS:5613092-4
- 17,003 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5560504-3Canonical exit: 29 May 2025 (T+90)
- 74,477 sharesOutside a trading venueISIN GB00B0LCW083RNS:5139884-4
- 34,570 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5103062-3Canonical exit: 10 Jun 2024 (T+90)
8 of 8 declarations